Skip to content
Company Analysis

IDEXX Laboratories, Inc. IDXX

A comprehensive view of key metrics, scores, and financial health for IDEXX Laboratories, Inc.

Overview of IDEXX Laboratories, Inc.

IDXX NMS
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
IDEXX Laboratories, Inc. (IDXX), is a Large Cap company, in the Diagnostics & Research industry, last closed at $552.46, about 81.2% overvalued vs fair value, -3.4% 1Y return, placing in the top 25% of its sector.
Metrics P/E 51.7× Rev Growth 10.4% ROE 66.2% Gross Margin 61.8%
USD 552.46
-2.01%
(Delayed)
• Vol 90d: 32.1%
52-Week Range
Market Cap
$44.06B
Enterprise Value
$44.97B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 82%
Confidence: 85%
Updated: Jul 5
Top Beats

Quick Facts

Website https://www.idexx.com
HQ Westbrook, ME
Employees 11,000
Fiscal year Dec 31

Next Events

Earnings Aug 3 Estimated

Fair Value Snapshot

Bear Base Bull
$93
$104
$115
Current: $552.46 -81% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$4.3B
10.4%%
Gross Profit
$2.7B
11.8%%
Operating Income (GAAP)
$1.4B
20.5%%
EBITDA
$1.5B
18.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
61.8%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
1
Active Leaks
0/1
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating IDEXX Laboratories, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
75
/100
Strong
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
72
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing IDXX's balance between Growth (28.4%), Profitability (46.8%), and Safety (24.8%). Growth 28% Safety 25% Profitability 47%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

56th percentile vs peers
56
Key Signals
Rev Growth YoY 10.4% 59p Revenue CAGR 3Y 8.5% 55p EPS Growth YoY 22.6% 48p EPS CAGR 3Y 17.7% 62p
Strengths
  • Interest Coverage Ratio in top 20% of peers (35.08, 93th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Operating Margin in top 20% of peers (31.6%, 98th percentile)
  • ROIC in top 20% of peers (44.4%, 96th percentile)
Risks

No significant risks identified for this axis.

Profitability

92th percentile vs peers
93
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

49th percentile vs peers
49
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for IDEXX Laboratories, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$103.74
- - -
-81.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000